These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 9636141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.
    Kliger Y, Aharoni A, Rapaport D, Jones P, Blumenthal R, Shai Y.
    J Biol Chem; 1997 May 23; 272(21):13496-505. PubMed ID: 9153194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.
    Lawless MK, Barney S, Guthrie KI, Bucy TB, Petteway SR, Merutka G.
    Biochemistry; 1996 Oct 22; 35(42):13697-708. PubMed ID: 8885850
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Capture of an early fusion-active conformation of HIV-1 gp41.
    Furuta RA, Wild CT, Weng Y, Weiss CD.
    Nat Struct Biol; 1998 Apr 22; 5(4):276-9. PubMed ID: 9546217
    [Abstract] [Full Text] [Related]

  • 10. Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
    Champagne K, Shishido A, Root MJ.
    J Biol Chem; 2009 Feb 06; 284(6):3619-27. PubMed ID: 19073602
    [Abstract] [Full Text] [Related]

  • 11. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM, Mobley PW, Pilpa R, Sherman MA, Waring AJ.
    Biochim Biophys Acta; 2002 Feb 15; 1559(2):96-120. PubMed ID: 11853678
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R, Decroly E, Kieny MP, Fenouillet E.
    Virology; 2000 Jul 20; 273(1):169-77. PubMed ID: 10891419
    [Abstract] [Full Text] [Related]

  • 15. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS, Rawat SS, Jiang S, Blumenthal R.
    Biochemistry; 2003 Dec 09; 42(48):14150-8. PubMed ID: 14640682
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]

  • 20. Membrane perturbing actions of HIV type 1 glycoprotein 41 domains are inhibited by helical C-peptides.
    Mobley PW, Barry JA, Waring AJ, Sherman MA, Gordon LM.
    AIDS Res Hum Retroviruses; 2007 Feb 25; 23(2):224-42. PubMed ID: 17331029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.